INmune Bio, Inc. (INMB) Tops Q2 EPS by 14c

INmune Bio, Inc. (NASDAQ: INMB) reported Q2 EPS of ($0.05), $0.14 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.

You May Also Be Interested In

• Mosaic (MOS), Others Lower Following Trump Post on Potash from Belarus
• Lumentum shares climb on optical AI demo with Qualcomm
• Coinbase (COIN) call put ratio 2.3 calls to 1 put as share price up 5.6%